Volitionrx (VNRX) Cash from Investing Activities (2011 - 2025)
Volitionrx (VNRX) reported Cash from Investing Activities of -$10967.0 for Q4 2025, up 94.46% on a YoY basis from -$5639.8 in Q4 2024, and up 85.72% quarter-over-quarter from -$76783.0 in Q2 2025.
Volitionrx (VNRX) Cash from Investing Activities (2011 - 2025) Analysis & Trends
Volitionrx has reported Cash from Investing Activities for 15 years, with the latest figure at -$10967.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities rose 94.46% year-over-year to -$10967.0; the trailing twelve-month figure through Dec 2025 stood at -$89558.0 (up 84.39% YoY), and the FY2025 full-year result was -$89558.0, up 84.39% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$10967.0, up from -$76783.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$1808.0 in Q1 2025, with the low at -$578752.0 in Q4 2022.
- Historically, Cash from Investing Activities has averaged -$225836.8 across 5 years, with a median of -$197859.0 in 2024.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities tumbled 1047.15% — and 2025, when it soared 97.71%.
- Volitionrx's Cash from Investing Activities stood at -$128572.0 in 2021, then sank by 350.14% to -$578752.0 in 2022, then soared by 46.66% to -$308722.0 in 2023, then jumped by 35.91% to -$197859.0 in 2024, then surged by 94.46% to -$10967.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$10967.0 (Q4 2025), -$76783.0 (Q2 2025), and -$1808.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Volitionrx | 50.28 Mn | 47.81 Mn | -1.01 Mn | -10,967.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10,967.00 |
| Dec 31, 2025 | -10,967.00 |
| Jun 30, 2025 | -76,783.00 |
| Jun 30, 2025 | -76,783.00 |
| Mar 31, 2025 | -1,808.00 |
| Mar 31, 2025 | -1,808.00 |
| Dec 31, 2024 | -197,859.00 |
| Dec 31, 2024 | -197,859.00 |
| Sep 30, 2024 | -136,737.00 |
| Sep 30, 2024 | -136,737.00 |
| Jun 30, 2024 | -160,447.00 |
| Jun 30, 2024 | -160,447.00 |
| Mar 31, 2024 | -78,809.00 |
| Mar 31, 2024 | -78,809.00 |
| Dec 31, 2023 | -308,722.00 |
| Dec 31, 2023 | -308,722.00 |
| Sep 30, 2023 | -273,041.00 |
| Sep 30, 2023 | -273,041.00 |
| Jun 30, 2023 | -301,394.00 |
| Jun 30, 2023 | -301,394.00 |